Search - Institut Bergonié Access content directly

Filter your results

1 Résultat
Deposit type : Notice

Selective Oral MEK1/2 Inhibitor Pimasertib in Metastatic Melanoma: Antitumor Activity in a Phase I, Dose-Escalation Trial.

Céleste Lebbé , Antoine Italiano , Nadine Houédé , Ahmad Awada , Philippe Aftimos , et al.
Targeted Oncology, 1970, 16 (1), pp.47-57. ⟨10.1007/s11523-020-00767-1⟩
Journal articles hal-03618177v1